Title: Overview
of Z score Neurofeedback training, 4-channel designs and 4
channel MINI-Q assessment and training
Dr Collura will present an overview of how Z score training
eliminates the hit and miss of knowing what to train and for
how-long, on account of the trained measure being
continuously compared those of to
a normative database. In
addition Dr Collura will introduce the concept of EEG
archetypes based on 4-channel Mini-QEEG for assessment
and 4 channel montages for
Neurofeedback. These concepts will be more fully discussed
with implementation protocols in the pre-conference
workshop.
Title: (Part 1) Foundations of Neurofeedback and Z score
Neurofeedback training
(Part 2) 4 channel designs
and 4-channel MINI-Q assessment and training
Abstract:
The first part of this workshop will discuss the
technical foundations of neurofeedback, with an emphasis on
neurophysiological aspects of coherence, phase, and
synchrony training. A signal is traced from its origin in
the brain, through the instrumentation, until a visual or
auditory feedback signal is presented to the trainee. Among
the topics covered will be: local and global synchrony,
origins of bioelectric rhythms, measurement and feedback of
coherence, phase, and synchrony, amplitude and phase
relationships in the EEG, and practical methods for training
global brain connectivity.
This will be followed by a discussion on Z score training
using Brainmaster 3.0 software. Z score training eliminates
the hit and miss of knowing what to train and for how-long.
The trained measure (amplitude, phase or coherence) is
continuously compared to
Dr Robert Thatcher's
normative database (Applied Neurosciences Inc.). Training
towards
a
Z score
of Zero is tantamount to training towards normalisation of
the trained measure.
In the second part of the workshop, Dr Collura will describe the use of 4-channel designs, and the use of the 4 channel MINI-Q (using Dr Robert Thatcher's normative database) for assessment and training. A new concept of EEG "archetypes" based upon 4-channel montages will be presented along with functional and clinical correlates and the implicatuions for a more scientific approach to the determination of Neurofeedback training protocols that are theory and QEEG driven.
Title: Pathways to Illness, Pathways to Health:
Applications of Mind-Body Medicine to Common Medical
Disorders.
Abstract:
This workshop provides a comprehensive mind-body framework
for intervening with medically ill patients, based on the
Pathways to Illness paradigm (McGrady & Moss, in
preparation). Sixty to seventy percent of patients entering
primary care present complaints which would benefit from
mind-body intervention. The majority of these patients
receive routine medical care, including medical testing,
medication, and/or referral to a medical specialist. Those
referred to mental health specialists frequently refuse
referral, and become more focused on medical/physical causes
and solutions. Yet if given a choice, many of these
patients will seek out complementary and alternative
medicine (CAM) therapies, many with no documented
effectiveness.
This workshop advocates a comprehensive model for integrating behavioral, behavioral, psychophysiological, and lifestyle changes into health care.
The model begins with a presentation of the Pathways to Illness paradigm, illustrating specific life style choices, environmental conditions, psychophysiological mechanisms, and cognitive/affective dysregulation processes, which lead the individual to the illness condition.
The workshop then proceeds to describe a comprehensive assessment which identifies the patient’s individual pathway to illness: genetic, lifestyle, nutritional, and psycho-physiological factors which dispose the patient to illness.
The emphasis is on identifying turning points and choices, which are amenable to voluntary control and self-regulatory change strategies.
Finally, patients who understand the pathways that brought them to illness are more motivated to walk the pathway toward health.
The workshop will highlight the development of a prescriptive individualized pathway for health, including facing difficult behavioral and life-style changes. Mind-body therapies including biofeedback, hypnosis, and meditative techniques supplement lifestyle interventions in restoring health.
Dr Moss will briefly review the outcome literature to identify disorders for which mind-body therapies have demonstrated positive efficacy. Specific applications will be discussed, moving beyond the bounds of typical psychological practice: headache, diabetes, cardiovascular disorders, irritable bowel syndrome, fibromyalgia, and lupus erythematosis. For each of these disorders, life-style, risk behaviors, and psychophysiological patterns will be reviewed, which can contribute to the pathogenesis of disease, and which can also serve as the basis for a restoration to health. Special attention will be given to heart rate variability biofeedback for its expanding applications to a variety of health care problems.
Workshop Objectives
At the
end of this workshop, attendees will be able to:
identify categories of medical patients who respond poorly to routine biomedical treatment,
conduct an assessment which identifies the patient’s pathway to illness: genetic, lifestyle, nutritional, and psychophysiological factors which dispose the patient to illness,
discuss strategies to reframe the “pathway to illness” as a potential “pathway to health” for the patient, increasing the motivation and readiness for behavioral and life-style change,
summarize which mind-body therapies have been supported by well constructed outcomes research,
recognize and understand specific medical disorders, which have been shown to respond positively to life-style change and mind-body therapies, and
use case history material, to understand methods for integrating mainstream medical care with the “pathways model,” in an integrative medicine paradigm.
Donald Moss, Ph.D., is the Director of Integrative Health Studies at Saybrook Graduate School in San Francisco, and is a partner in the Psychological Services Center in Grand Haven, Michigan. He is Editor of the Biofeedback Magazine, Associate Editor for the journal Applied Psychophysiology and Biofeedback, and Consulting Editor for the Journal of Neurotherapy, Psychophysiology Today, and the Journal of Phenomenological Psychology. Dr. Moss has over 50 publications in the fields of psychophysiology, biofeedback, and mind-body therapies, including an edited book (Handbook of Mind Body Medicine for Primary Care, Sage, 2003). He has given lectures and workshops on these topics throughout the world, including recent presentations at the Association for Applied Psychophysiology and Biofeedback, the International Association for Cognitive Psychotherapy, the National Autonomous University of Mexico, and the Biofeedback Foundation of Europe. He is also past-president of AAPB.
The QEEG and how to translate it into Neurotherapy protocols for patterns associated with Depression, Anxiety, ADHD, Tourette Syndrome and OCD: A Phenotype Approach.
Research
has shown that QEEG-guided neurofeedback is superior to the
symptom based approach. Initially, normalization of deviant
activity was applied in order to decrease a range of
complaints. Recently, EEG phenotypes
have been suggested. For example, within the low beta-power,
high theta-power profile of children with ADHD, sub groups
have been identified, having frontal beta spindles or
frontal alpha. This variability has been associated with the
limited effects of medication.
Although most research concerns itself with EEG power,
recently the role of coherence has received more attention.
Besides, brain processes in, e.g., depression, anxiety,
ADHD, Tourette Syndrome and OCD have EEG representations,
which have been used in neurofeedback.
The workshop will start with an introduction into EEG, QEEG
and phenotypes. Then, the five domains will be discussed.
The focus of the workshop will be on hands-on QEEG
interpretation and protocol development.
At the end of the workshop the participants will have knowledge about :
The morphology of the raw EEG and its importance for QEEG maps
How to interpret QEEG maps
The various phenotypes and their role in depression, anxiety, ADHD, Tourette Syndrome and OCD .
Practiced (limited) hands-on experience in how to interpret Raw EEG
How to describe QEEG maps,
How to develop neurofeedback protocols in five clinical domains.
Dr. Rien Breteler is a chartered psychologist in the Dutch Health Care system. He has been Associate Professor in Clinical Psychology at the Radboud University Nijmegen since 1987. From 2003 and onwards he has been involved in Neurofeedback research and practice. Currently he is president of the Neurofeedback section of the Dutch Psychologists' Association NIP. He is also director of the Neurofeedback curriculum of the Biofeedback Federation of Europe (BFE) (Netherlands).
Rien Breteler is convinced that neurofeedback will be able to make a considerable contribution to mental and physical health care, in particular where psychotherapy and pharmacotherapy are inadequate. This trend may already be seen in ADHD treatment. An increasing number of parents prefer neurofeedback due to the side-effects of medication. Rien Breteler is involved in various studies concerning the conditions for effective application of neurofeedback.
Title: Overview
of Z score Neurofeedback training, 4-channel designs and 4
channel MINI-Q assessment and training
Dr Collura will present an overview of how Z score training
eliminates the hit and miss of knowing what to train and for
how-long, on account of the trained measure being
continuously compared those of to
a normative database. In
addition Dr Collura will introduce the concept of EEG
archetypes based on 4-channel Mini-QEEG for assessment and 4 channel montages for
Neurofeedback. These concepts will be more fully discussed
with implementation protocols in the pre-conference
workshop.
Presentation:: Brain Processes in Dyslexia and their Consequences for Neurofeedback: A Review of Current Developments and Future Directions.
About 15% of the population differs from normals in reading and writing ability due to dyslexia, a specific disorder in the language system. The phonological deficit theory concerning decoding and identification of text has received most support. A “dyslexic triad” has been postulated consisting of poor phonological awareness, poor verbal short-term memory and slow lexical retrieval. Recent research suggests the importance of memory load, explaining why most children with dyslexia can correctly repeat one- and two-syllable nonwords. The temporo-parietal system, a system in the left occipito-temporal area, and an anterior system in the inferior frontal gyrus have been suggested to be involved in dyslexics’ problems in reading and writing. Besides, coherence abnormalities between frontal and central/posterior areas appear to play a role.
In the light of these findings neurofeedback treatment research for dyslexia will be discussed. Group studies, including the first randomized neurofeedback treatment study (with Effect Sizes up to 3.0), allow for the estimation of the effectiveness of neurofeedback as a health care intervention. Case studies allow for showing the dynamics of change processes. QEEG-guided neurofeedback, addressing the left occipito-temporal word form area during reading, and coherence, may be one of the most promising interventions for dyslexia of the current century.
Presentation:: User-Friendly Mind-Body Therapies for Health Care Abstract: Increasingly, patients suffer from disorders produced by exposure to stressful environments and by maladaptive life styles that dispose one to illness. Mind-body therapies reverse the effects of the human stress response and moderate the symptoms of many common medical disorders. Mind-body approaches provide useful adjuncts to mainstream medical care. In many cases fairly minimal interventions, of brief duration, can make significant differences in the patient’s symptoms and quality of life. Dr Moss will identify a wide range of medical diseases and conditions, for which such mind-body interventions have demonstrated effectiveness.
Neuroscientist from the Brain Sciences Institute, Faculty of Life and Social Sciences, Swinburne University of Technology, Melbourne Australia, and Howard Florey Institute, Melbourne, Australia. Professor Silberstein founded the Brain Sciences Institute and headed the team of scientists who developed the Steady State Visually Evoked Potential (SSVEP) technology used at the BSI.
Presentation: Creativity, Dopamine and Attention Deficit Hyperactivity Disorder
Dr Chris Millar
MBBS Dr
Millar graduated from Melbourne University with a medical
degree in 1980. He has post-graduate training in
Psychological Medicine (Monash University), Psychiatry
(Lakeside Mental Hospital), Family Therapy (VAFT),
Nutritional Medicine (ACNEM) and Clinical Research
(Newcastle University). In the last five years he has
pursued various biofeedback modalities (EEG, HRV and HEG)
and applied them to daily clinical practice. He considers
himself an applied scientist who takes a systems analyst
approach to addressing clinical presentations. He has worked
in a primary care role as a general practitioner for over 25
years.
Presentation:
Biofeedback in General Practice.
The psychophysiological basis of biofeedback
makes it an ideal modality for medically trained clinicians.
The nature of everyday general practice work is such that it
provides a ready supply of problems with potential
biofeedback solutions: in particular, depression, anxiety,
stress, and insomnia. Combined with nutritional and
lifestyle advice it offers an effective and vital middle
way between supportive counselling/CBT and
medication/surgery. Five years of experience integrating
biofeedback (EEG and HRV) into mainstream general practice
will be presented.
Dr Angelo Schibeci,
BA (Hons Psych), BSc, MSc, PhD, MAPS, MANSA
Angelo is a registered psychologist in private practice for
the past ten years. After he received his PhD in
Biochemistry, he pursued a career in Biomedical Research in
Canada, USA and Australia. In 1985 he made a career change
and studied Psychology at the University of Wollongong and
obtained an Honours degree in Psychology from Macqurarie
University in 1988. After graduating in Psychology he worked
as an organisational psychologist before joining the
Department of Corrective Services in 1994. In 1997, he was
introduced to Neurofeedback and received training in this
field in Los Angeles, California. There he trained with
Siegfried and Sue Othmer from EEG Spectrum, and Professor
Sterman of the UCLA. He has also trained with various other
experts in this field including Jay Gunkelman, Lynda &
Michael Thompson, Richard Gevirtz. He has applied
Biofeedback and Neurofeedback in his practice in the last 10
years. Angelo has considerable clinical experience working
with adults and children suffering from a variety of
disorders including ADHD, Depression, Anxiety, OCD, PTSD,
post-concussion syndrome, and Chronic
Pain.
Presentation: QEEG
features and neurofeedback treatment in Asperger’s Syndrome.
Although patients with
Aspergers syndrome present with heterogeneous EEG profiles,
it appears that certain regions of the brain show common
impairments. Nonetheless, Neurofeedback has been
demonstrated to be a successful intervention in the
treatment of this disorder. Statistically significant
changes before and after neurofeedback treatment have been
demonstrated in the QEEG. These changes have been correlated
with positive outcomes in objective measures.
Nerida Saunders,
BA,
Dip Ed, Graduate Dip Coun, M Phil. Nerida Saunders has been in private
clinical practice for 15 years and is the Clinical Director of a busy
practice employing and supervising psychologists and interns. She has
also established a BRC qEEG laboratory and has been trained by Dr. Rien
Breteler (Head of Neurofeedback with the Dutch Psychological Society)
and Dr. Martijn Arns, from Brainquiry, Netherlands in qEEG
interpretation and qEEG protocol driven Neurofeedback. Nerida is
president of the Gold Coast Division of the Australian College of
Clinical Psychologists, is President elect of the Applied Neuroscience
Society of Australasia, and is a member of EMDRI, the international
organization for EMDR. She has also set up a unique Memory Clinic in
conjunction with Neuropsychiatrist Dr. Philip Morris and Dr. Rustam
Yumash.
Presentation:
International Study
investigating the efficacy of neurofeedback (NF) on brain
function, cognitive performance, clinical symptomatology and
behavior in 500 AD/HD subjects.
The International
Study of Attention-Deficit/Hyperactivity Disorder
Neurofeedback Efficacy (iSANE) will investigate the efficacy
of neurofeedback (NF) on electroencephalographic (EEG) brain
function, cognitive performance, clinical symptomatology and
behavior in 500 AD/HD subjects. The trial protocol has been
established according to CONSORT (Consolidated Standards of
Reporting Trials) guidelines. This study involves a
“naturalistic” observation of NF within various clinics
across the world. Clinicians will conduct “treatment as
usual” with their clients (i.e., diagnostic intake, change
protocols based on clinical judgment, etc.). In order to
study the effects of NF on outcomes across sites, certain
guidelines must be implemented. These guidelines will
involve standardized procedures and materials. Nerida will
outline the four stages of this study as well as guidelines
and the standardized procedures n this presentation.
Jacques Duff:
BA Psych, Grad Dip Psych. Jacques Duff is
the Clinical Director of the Behavioural Neurotherapy
Clinic. Since 1997 he has been involved in Clinical
Neuroscience research at the Brain Sciences Institute,
investigating the causes of ADHD and its treatment using
Neurotherapy. In addition to being a psychologist, he has
Postgraduate training in Clinical Neuroscience and
Nutritional and Environmental Medicine.
Presentation: QEEG,
Anxiety and intestinal overgrowth of Streptococcus.
There is much evidence suggesting
that Irritable Bowel Syndrome (IBS) is asociated with
intestinal dysbiosis (abnormal distribution of comensal
bacteria). There is also evidence that around 70-90% of
people with IBS report a psychiatric disorder, mostly
anxiety and depression. We present evidence that anxiety and
panic disorder is frequently asociated with an overgrowth of
streptococcus measured with faecal microbiology analysis(FMA).
We compared the FMA and QEEG of clients with severe anxiety
and panic attacks to those of clients without this
presentation. Patients with anxiety and panic disorder had
significantly more beta wave activity and streptococcus
overgrowth. Suggestions are offered for a possible mechanism
to explain this finding and implications for treament are
presented.
Dr Paul Mahoney
BEd, DPsych Sport & Exercise Psychologist
Presentation:
EEG assessment and
Neurofeedback applied in a sporting context. EEG
activity and Neurofeedback has been used in a variety of
ways to enhance performance. This presentation will outline
the dynamic use of EEG assessments and Neurofeedback
techniques for performance enhancement. Much of the research
suggests that associations between EEG activity and sporting
performance reflect a large amount of individual difference.
It follows that Neurofeedback interventions would be more
effective if they were tailored to the specific needs of the
individual and their own performance. A number of assessment
strategies that aim to individualise the intervention will
be described. In particular a QEEG assessment will be
compared to the use of only one or two channels. These
strategies compare the EEG activity at different levels of
individual performance rather than a norm. Therefore, this
assessment can be used as an alternative or in addition to a
QEEG database. The interventions derived from these
assessments can be used for contemporary Neurofeedback
techniques or a dynamic form of Neurofeedback that responds
to the needs of the sporting task. The challenges and
drawbacks of working with EEG in the sporting field will be
outlined. Some contexts lend themselves more readily to EEG
measurement. The application of these techniques in the
context of Olympic trap shooting, professional golf and
state cricket will be discussed.
Mirjana Askovic and Sejla Tukelija,
Psychologists NSW Service for the Treatment
and Rehabilitation of Torture and Trauma Survivors (STARTTS)
Presentation:
Neurofeedback Therapy in Work
with Complex Trauma Focusing on Affect Dysregulation
This presentation will cover STARTTS experiences
in using neurofeedback with clients suffering complex
trauma. The paper will address the theoretical underpinning
of working with complex trauma, particularly focusing on
issues of affect dysregulation. A detailed case study of a
14 years old African boy will illustrate the practical
application of neurofeedback training in resolving
longstanding issues of severe anger and impulse control
Gordana Hol:
Psychologist NSW Service for the Treatment and
Rehabilitation of Torture and Trauma Survivors (STARTTS)
Presentation:
“Utilising Heart Rate Variability (HRV) as an
integrative approach to assessment and treatment in torture
and trauma survivors”
The focus of this presentation is on the utilisation of
Heart Rate Variability (HRV) as one of the approaches
working with STARTTS clients. A case presentation is based
on theoretical background and rational for implementation of
HRV. The aim is to discuss HRV as an assessment tool, as
well as a therapeutical clinical component of our work with
a female torture and trauma survivors from Iraq.
Dr Donald L. Rowe PhD (med.) M. Clin. Psyc. BSc(hons) MAPS
Donald Rowe is the founder and Managing Director of
Psychological Consult. He is a clinical neurophysiologist
and consulting psychologist with a PhD in psychological
medicine from the University of Sydney, a Masters of
Clinical Psychology from the University of Wollongong and a
Bachelor of Science (Psychology) degree (with first class
honours) from the University of WA. He has over 10 years
experience working in the area of psychology and medicine
including both practicing and lecturing in the area of
clinical psychology. Before training as a clinical
psychologist, he developed his skills as a psychotherapist
in the area of psychodynamic/self psychology under the
supervision of eminent WA psychiatrist Dr Hans Stampfer. He
also has a high level of expertise in the area of
neuropsychology and psychophysiology (EEG), currently
working as a consultant for the Brain Resource Company and
as a consultant for medicolegal, geriatric and peadiatric
cases. Donald currently holds honorary associate positions
with the Brain Dynamics Centre, the Dept. of Psychological
Medicine, Westmead Hospital and University of Sydney, and
the School of Physics (neuroscience), University of
Sydney.
Presentation: Review
test-retest reliability of coherence measures in the EEG and
application to NF and other clinical applications with case
examples.
Dr Donald Moss,
Presentation
PTSD, Incidence in Chronic Illness and
Returning Combat Veterans, and Psychophysiological
Therapies.
This presentation will highlight the prevalence and costs
of PTSD, in the general population and in populations
exposed to traumatic events, and will also emphasize factors
that increase the risk for PTSD and subsyndromal
post-traumatic symptoms.
From the beginning, PTSD has been seen as a condition of mind and body -- a “physioneurosis” as Abraham Kardiner described it. The psychophysiological nature of PTSD is supported by research which shows the involvement of sub-cortical brain structures, direct sensory pathways to the limbic system, affective dysregulation, and the presence of chronic measurable activation of the sympathetic nervous system. The psychophysiological nature of PTSD limits the effectiveness of purely verbal or cognitive therapies, and indicates a need for affectively oriented mind-body therapies.
Post Traumatic Stress Disorder was initially recognized as a syndrome precipitated by combat and the experiences of war. Gradually the concept of PTSD was extended to other traumatic and life-threatening experiences, such as auto accidents, rape, assaults, and natural disasters. Since the development of the DSM-IV, the signs and symptoms of post-traumatic experiencing have also been recognized in cancer, burns, and other chronic illnesses. The presenters will highlight some of the research available on the presence of PTSD in cancer, burns, and other chronic diseases.
The
presenter will also touch on efforts to develop biofeedback
and mind-body oriented programs for returning veterans from
the Iraq and Afghan conflicts. Finally, the presenter will
review the relatively scant data on the applications of
psychophysiological treatments, including biofeedback and
hypnosis, to PTSD.
Dr Rien Breteler to be announced.
Panel
Discussions
after lunch
1. Approaches to neurofeedback & future
direction
(Saturday)
2. Accreditation (discussion of proposed models)
(Sunday)